BioCentury
ARTICLE | Financial News

Reliant amends IPO

October 26, 2007 1:48 AM UTC

Cardiovascular company Reliant (Liberty Corner, N.J.) amended its IPO and hopes to sell 10 million shares at $25-$27 in an offering underwritten by Goldman Sachs; Merrill Lynch; JPMorgan; Banc of America Securities; and Lazard. A $26 price would raise $260 million and value the company at $1.3 billion. Selling shareholders plan to sell an additional 1.7 million shares. The company originally filed to raise up to $300 million in May 2005 but withdrew the proposal later that year, citing market conditions. In August, the company refiled to raise up to $400 million. ...